Cardiometabolic disease, a term encompassing a cluster of conditions that increase the risk of cardiovascular disease and metabolic disorders, represents a significant health challenge in today's society. This multifaceted group includes conditions such as obesity, type 2 diabetes, and hypertension, which collectively contribute to an elevated risk of heart disease and stroke. The intricate interplay between genetics, lifestyle factors, and environmental influences underscores the complexity of cardiometabolic diseases. Sedentary lifestyles, poor dietary choices, and genetic predispositions can contribute to the development and progression of these interconnected conditions. Early detection and comprehensive management strategies are crucial in mitigating the impact of cardiometabolic disease, emphasizing the importance of lifestyle modifications, medication adherence, and regular health screenings. Public health initiatives aimed at promoting awareness, education, and preventive measures play a pivotal role in addressing the rising prevalence of cardiometabolic disease and fostering a healthier population.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia